US 10934550
Immunotherapy of cancer
granted A61KA61K40/11A61K40/4224
Quick answer
US patent 10934550 (Immunotherapy of cancer) held by Phio Pharmaceuticals Corp. expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Phio Pharmaceuticals Corp.
- Grant date
- Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K40/11, A61K40/4224, A61P, A61P31/00